Skip to main content
Top

06-11-2019 | Semaglutide | ADA 2019 | Article

Researcher comment: The PIONEER 6 oral semaglutide cardiovascular outcomes study

print
PRINT
insite
SEARCH

PIONEER 6 lead investigator Mansoor Husain discusses the results of the trial, and how oral and injectable semaglutide compare and can be used in the clinic (4:40).

More on this topic

print
PRINT

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »